View source for Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI

Jump to navigation Jump to search

You do not have permission to edit this page, for the following reason:

The action you have requested is limited to users in the group: Users.

You can view and copy the source of this page.

Return to Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI.

Retrieved from "https://www.wikidoc.org/index.php/Angiomax_Monotherapy_Associated_with_Reduced_Net_Adverse_Clinical_Events,_Major_Bleeding_and_Cardiac‐Related_Death_Compared_to_Heparin_Plus_a_Glycoprotein_IIb/IIIa_Inhibition_in_Primary_PCI:_Results_of_HORIZONS_AMI"